source
- FDA officials stress administration priorities in draft PDUFA VIII commitment letterAt a public meeting on Wednesday, FDA officials presented the proposed commitment letter for the upcoming PDUFA VIII program. The letter reiterates the administration's priorities, reflecting the…
- Novartis drops $125M for Sironax’s tech to cross blood-brain barrierNovartis stands alongside Big Pharma peers that have similarly invested in technologies to penetrate the blood-brain barrier, including GSK, Roche and Eli Lilly.BioSpace · 1mo ago↗ source